SWM
TTOO

SeaCrest Wealth Management’s T2 Biosystems, Inc TTOO Stock Holding History

SeaCrest Wealth Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-6
Closed -$89K – 2247
2018
Q4 		$89K Buy
6
+1
+20% +$23.5K 0.02% 702
2018
Q3 		$197K Buy
5
+2
+67% +$65.9K 0.03% 506
2018
Q2 		$132K Buy
+3
New +$114K 0.02% 635

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SeaCrest Wealth Management's TTOO Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of T2 Biosystems, Inc (TTOO) in Q1 2019, closing a stake of 6 shares — an estimated $89K sold.

SeaCrest Wealth Management first reported a position in TTOO in Q2 2018 and held it in 3 quarters. The position peaked at $197K in Q3 2018. 71 funds tracked by Wall St. Rank hold TTOO as of Q1 2019.

  • SeaCrest Wealth Management reported no remaining T2 Biosystems, Inc position as of Q1 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 6 T2 Biosystems, Inc shares in Q1 2019, an estimated $89K.
  • SeaCrest Wealth Management first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 3 quarters.
  • SeaCrest Wealth Management's T2 Biosystems, Inc position peaked at $197K in Q3 2018.
  • 71 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.